to view mpsu activities please click below
http://www.kck.usm.my/mpsu/.
MPSU will commence with its
surveillance and paediatricians interested to conduct research are
invited to submit proposals.
Closing Date: 15 May
2002
Please contact:
Dr Rowani Mohd Rawi / Dr
Sharifah Ainon
Malaysian Paediatric
Surveillance Unit
Department of Paediatric
School of Medical Sciences
Universiti Sains Malaysia
16150, Kubang Kerian,
Kelantan
Phone: +609 7651711 ext 3633
Fax: +609 7653370
|
The history of MPSU:The Malaysian Paediatric
Surveillance
Unit was formed in 1994 and most of the work was undertaken by Dr
Jackie Ho. Dr Amar Singh and Dato' Dr A Jai Mohan.The
paediatricians from Ipoh ran the MPSU until the year 2000. The studies which
were most helpful to the paediatricians in the country included
the study on asthma deaths (see below), acute liver necrosis and
congenital heart disease in the newborn period. The MPSU has been
funded by grants from the Malaysian Paediatric Foundation and fees
collected from researchers. After a period of 6 years the MPSU has
now been taken over by a team from Hospital USM, Kubang Kerian,
Kelantan (to be announced). The MPA would like to thank Dr Jackie
Ho, Dr Amar Singh, Dato' Dr A Jai Mohan and their team in Ipoh,
Perak for their good effort and hard work over the many years.
BRONCHIAL ASTHMA DEATHS IN MALAYSIAN CHILDREN: A 3 1/12 YEAR
SURVEILLANCE STUDY (presented at the 21st Annual Congress of the
MPA 5-8/9/99)
GL Kuan Departnient of Paediatrics, Hospital Malacca, Malacca, Malaysia
With the help of the Malaysian Paediatric Surveillance Unit (MPSU)
a surveillance system conducted by Malaysian Paediatric Association
(MPA), a 3 1/2 year study (March 1994 - August 1997) was conducted
to (1) determine the number of asthma deaths that occur in children
less then 12 years old, (2) study the risk factors associated with
these deaths and finally (3) identify if these deaths were preventable.
Within the study period, the MPSU were notified monthly by paediatricians
who were members of MPA throughout the country, of any asthma deaths
that occurred. The MPSU would notify the author, who would then
contact the paediatricians concerned to fill up a data sheet. During
the study period, there were 35 notifications but only 12 replies
(34% response rate). Of the 12 cases reported, only 10 cases will
be discussed as two cases had incomplete data There was no seasonal
pattern in the occurrence of the deaths. The male:female ratio in
this series of 10 deaths were equal; 7 were Malays, 3 were Chinese
and 1 was an Indian child. The ages of the patients ranged from
1.4 years to 11 years; the mean age was 5.6 years. All were known
asthmatics except one; and 8 patients had history of onset of asthma
at <2 years of age. Eight of the patients had reduced growth (weight
<3%). Only 4 patients were on prophylaxis. Long term under supervision
and under treatment was felt to be the underlying preventable contributory
factor in 6 of the deaths. Poor perception of the fatal attack on
the part of the parents was felt to be a preventable contributory
factor in 7 of the cases; and on the part of the attending doctor
in one of the cases. There was delay in seeking treatment in the
fatal cases in 6 of the cases; a suboptimal treatment in 3 of the
cases. Asthma deaths in children is not as uncommon as perceived
by most doctors and parents. Nine of the deaths were potentially
avoidable had more emphasis been put on doctor and patient education
to improve long term undersupervision and under treatment. Deaths
from asthma in children is a reality that should be impressed on
parents to spur them to be more proactive and to seek treatment
early; and on doctors to provide optimal treatment.
|
|